Thank you for your interest in applying for the Bayer Hemophilia Awards Program. This program represents Bayer's continuing commitment to taking the next steps for the next generation of people with hemophilia to enjoy a better quality of life and treatment options.

Applications will be processed solely through the Internet and all applications must be submitted in English.

As a first step, applicants should submit a Letter of Intent describing the proposed project in 500 words or fewer. All Letters of Intent submitted will receive an e-mail confirming receipt.

Letters of Intent will be reviewed by all 16 members of the Grants Review and Awards Committee. In some cases, additional information may be requested.

Selected applicants will be invited to submit a full proposal that will be reviewed by at least two members of the Grants Review and Awards Committee. These applicants will be e-mailed a full application form.

The results of the review process and funding decisions will be communicated to applicants in May each year. Funded applicants must send a letter of acceptance and enter into an agreement outlining obligations and understandings prior to disbursement of funds.

Awardees will be invited to attend an Awards Dinner that will coincide with the bi-annual meetings of the World Federation of Hemophilia (WFH) or the International Society for Thrombosis and Hemostasis (ISTH).

The table below summarizes the application timelines for 2008/09.

Action	Date
Letter-of-intent submissions	permitted throughout year
Deadline for consideration for 08/09 cycle	November 30, 2008
Grants Review Committee reviews Letters of Intent	December 2008/January 2009
Grants Review Committee informs applicants	January 31, 2009
Applicants develop proposals	February 2009/March 2009
Full proposals submitted	March 2009
Grants Review Committee reviews full proposals	April/May 2009
Applicants notified of Committee decisions	May 2009
Funding available	July 2009